Stockreport

A Look at AnaptysBio's (ANAB) Valuation Following Promising Phase 2b Rosnilimab Results and Analyst Upgrades [Yahoo! Finance]

AnaptysBio, Inc.  (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations
PDF well beyond initial treatment and deepened across 28 weeks, regardless of previous therapies. See our latest analysis for AnaptysBio. Momentum around AnaptysBio has [Read more]